Evidence map›Paper›PMID 41701697›Full record

ArticlePloS one2026

96 sample parallel acoustic fragmentation for high throughput next generation sequencing library preparation.

Marjan Mehrab-Mohseni, Kathlyne Jayne B Bautista, Yusha Liu, Erika E Maldonado-Rosado, Haofan Zheng, Matthew J Niederhuber, Jonathan D Rosen, Michell D Carroll, Brian Velasco, James K Tsuruta and 8 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Marjan Mehrab-MohseniDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina, United States of America.
Kathlyne Jayne B BautistaLampe Joint Department of Biomedical Engineering, The University of North Carolina, Chapel Hill, North Carolina, United States of America.
Yusha LiuUNC Lineberger Comprehensive Cancer Center, Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Erika E Maldonado-RosadoBioinformatics and Analytics Research Collaborative, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Haofan ZhengStatistics & Operations Research, College of Arts and Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Matthew J NiederhuberBioinformatics and Analytics Research Collaborative, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Jonathan D RosenDepartment of Genetics, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0001-6396-4219
Michell D CarrollDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina, United States of America.
Brian VelascoLampe Joint Department of Biomedical Engineering, The University of North Carolina, Chapel Hill, North Carolina, United States of America.
James K TsurutaLampe Joint Department of Biomedical Engineering, The University of North Carolina, Chapel Hill, North Carolina, United States of America.
Jinwook KimLampe Joint Department of Biomedical Engineering, The University of North Carolina, Chapel Hill, North Carolina, United States of America.
James S MarronStatistics & Operations Research, College of Arts and Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Perry D HaalandStatistics & Operations Research, College of Arts and Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Sandeep K KasojiTriangle Biotechnology, Inc., Durham, N.C., United States.
Piotr A MieczkowskiDepartment of Genetics, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0003-2418-0096
Austin J HepperlaBioinformatics and Analytics Research Collaborative, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.ORCID https://orcid.org/0000-0002-0107-2001
Paul A DaytonLampe Joint Department of Biomedical Engineering, The University of North Carolina, Chapel Hill, North Carolina, United States of America.
Samantha G PattendenDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, North Carolina, United States of America.

Funding

Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applicationsR44CA232902 · NCI · TRIANGLE BIOTECHNOLOGY, INC. · PI KASOJI, SANDEEP, PATTENDEN, SAMANTHA GAIL · 2020 to 2021
$2.0M
Development of a cavitation enhancement technology to access archived tissues for epigenetic-based biomedical researchR01GM138912 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVIS, IAN J, PATTENDEN, SAMANTHA GAIL · 2021 to 2024
$1.7M
NCI NIH HHS R44 CA232902NIGMS NIH HHS R01 GM138912
6 · The paper itself

Abstract

Random, unbiased fragmentation of genomic DNA is necessary for next generation sequencing (NGS), yet the process of DNA fragmentation is still a bottleneck in NGS pipelines. A technology that increases the efficiency and consistency of this step will be highly desirable for both research laboratories and in clinical diagnostics. Previously, we reported the development of a novel cavitation enhancement reagent that dramatically decreases the time and acoustic energy required for genomic DNA fragmentation. The inclusion of this reagent in standard protocols facilitates highly efficient sonication enabling the use of widely available and inexpensive equipment, including water bath-based sonicators. Here, we report that cavitation enhancement facilitates parallel fragmentation of up to 96 samples of genomic DNA in a modified sonication device. The parallel processing of multiple samples significantly reduces processing time, while maintaining fragment range reproducibility and preserving DNA quality for NGS. Consequently, this system removes a key bottleneck in standard NGS pipelines and facilitates efforts toward research and personalized genomics.

Indexed as

AcousticsDNA FragmentationGene LibraryHigh-Throughput Nucleotide SequencingSonicationDNAHumansReproducibility of ResultsSequence Analysis, DNADNA

Identifiers

PMID41701697
PMCPMC12912608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.